康寧醫院(02120.HK)上半年淨利潤3650萬元 同比降低28.0%
格隆匯8月12日丨康寧醫院(02120.HK)公佈,2025年上半年,集團錄得營業收入爲人民幣738.6百萬元,較去年同期降低10.9%,其中,自有醫院運營收入達到人民幣690.9百萬元,較去年同期降低9.8%。報告期內,集團實現歸屬於公司股東的淨利潤爲人民幣36.5百萬元,較去年同期降低28.0%。
截至2025年6月30日,集團自有醫院增加至33家(2024年12月31日:32家),其中包括一家獨立設置的互聯網醫院(怡寧心理互聯網醫院),運營牀位數增加至11,818張(2024年12月31日:11,508張)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.